Can Entrectinib treat esophageal cancer?

Entrectinib (Entrectinib) is a targeted therapy drug mainly used to treat adult and pediatric solid tumors carrying NTRK gene fusions, as well as ROS1 gene fusion-positive advanced non-small cell lung cancer. Although esophageal cancer is a common malignancy, entrectinib is not currently a widely used drug for the treatment of esophageal cancer. For the treatment of esophageal cancer, the most appropriate treatment plan is usually determined based on the condition. Conventional treatments include surgical resection, radiotherapy, and chemotherapy. At the same time, targeted therapeutic drugs for esophageal cancer are also being continuously researched and developed. If patients need to use entrectinib to treat related diseases, they should do so according to the doctor's prescribing information.